Comments
Loading...

Anavex Life Sciences

AVXLNASDAQ
$6.58
0.6711.34%
At Close: -
$6.46
-0.12-1.81%
After Hours: 5:24 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$46.00
Lowest Price Target1
$11.00
Consensus Price Target1
$33.00

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Anavex Life Sciences (NASDAQ:AVXL) Stock, Analyst Ratings, Price Targets, Forecasts

Anavex Life Sciences Corp has a consensus price target of $33 based on the ratings of 5 analysts. The high is $46 issued by EF Hutton on July 22, 2024. The low is $11 issued by Cantor Fitzgerald on December 6, 2022. The 3 most-recent analyst ratings were released by EF Hutton, HC Wainwright & Co., and HC Wainwright & Co. on July 22, 2024, June 11, 2024, and May 10, 2024, respectively. With an average price target of $42 between EF Hutton, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 550.07% upside for Anavex Life Sciences Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

EF Hutton
HC Wainwright & Co.
BTIG
Cantor Fitzgerald
Berenberg

1calculated from analyst ratings

Analyst Ratings for Anavex Life Sciences

Buy NowGet Alert
07/22/2024Buy Now611.99%EF Hutton
Jason Kolbert
→ $46Initiates → BuyGet Alert
06/11/2024Buy Now519.12%HC Wainwright & Co.
Raghuram Selvaraju
$40 → $40ReiteratesBuy → BuyGet Alert
05/10/2024Buy Now519.12%HC Wainwright & Co.
Raghuram Selvaraju
→ $40ReiteratesBuy → BuyGet Alert
01/03/2024Buy Now519.12%HC Wainwright & Co.
Raghuram Selvaraju
$54 → $40MaintainsBuyGet Alert
11/28/2023Buy Now735.81%HC Wainwright & Co.
Raghuram Selvaraju
→ $54ReiteratesBuy → BuyGet Alert
08/08/2023Buy Now735.81%HC Wainwright & Co.
Raghuram Selvaraju
→ $54ReiteratesBuy → BuyGet Alert
07/20/2023Buy Now—HC Wainwright & Co.
Raghuram Selvaraju
—ReiteratesBuy → BuyGet Alert
06/29/2023Buy Now735.81%HC Wainwright & Co.
Raghuram Selvaraju
→ $54ReiteratesBuy → BuyGet Alert
05/02/2023Buy Now735.81%HC Wainwright & Co.
Raghuram Selvaraju
→ $54Reiterates → BuyGet Alert
03/31/2023Buy Now735.81%HC Wainwright & Co.
Raghuram Selvaraju
$50 → $54MaintainsBuyGet Alert
02/09/2023Buy Now333.38%BTIG
Yun Zhong
$35 → $28MaintainsBuyGet Alert
02/09/2023Buy Now673.9%HC Wainwright & Co.
Raghuram Selvaraju
→ $50Reiterates → BuyGet Alert
02/06/2023Buy Now673.9%HC Wainwright & Co.
Raghuram Selvaraju
→ $50Reiterates → BuyGet Alert
01/03/2023Buy Now673.9%HC Wainwright & Co.
Raghuram Selvaraju
$42 → $50MaintainsBuyGet Alert
12/06/2022Buy Now70.26%Cantor Fitzgerald
Charles Duncan
$16 → $11DowngradeOverweight → NeutralGet Alert
06/23/2022Buy Now519.12%Berenberg
Caroline Palomeque
→ $40Initiates → BuyGet Alert
02/02/2022Buy Now550.07%HC Wainwright & Co.
Raghuram Selvaraju
$39 → $42MaintainsBuyGet Alert
09/23/2021Buy Now441.73%BTIG
Yun Zhong
—Initiates → BuyGet Alert

FAQ

Q

What is the target price for Anavex Life Sciences (AVXL) stock?

A

The latest price target for Anavex Life Sciences (NASDAQ:AVXL) was reported by EF Hutton on July 22, 2024. The analyst firm set a price target for $46.00 expecting AVXL to rise to within 12 months (a possible 611.99% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Anavex Life Sciences (AVXL)?

A

The latest analyst rating for Anavex Life Sciences (NASDAQ:AVXL) was provided by EF Hutton, and Anavex Life Sciences initiated their buy rating.

Q

When was the last upgrade for Anavex Life Sciences (AVXL)?

A

There is no last upgrade for Anavex Life Sciences

Q

When was the last downgrade for Anavex Life Sciences (AVXL)?

A

The last downgrade for Anavex Life Sciences Corp happened on December 6, 2022 when Cantor Fitzgerald changed their price target from $16 to $11 for Anavex Life Sciences Corp.

Q

When is the next analyst rating going to be posted or updated for Anavex Life Sciences (AVXL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anavex Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anavex Life Sciences was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.

Q

Is the Analyst Rating Anavex Life Sciences (AVXL) correct?

A

While ratings are subjective and will change, the latest Anavex Life Sciences (AVXL) rating was a initiated with a price target of $0.00 to $46.00. The current price Anavex Life Sciences (AVXL) is trading at is $6.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch